Crossmark

HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

Crossref DOI link: https://doi.org/10.1186/s12967-015-0714-7

Published: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lanters, Eva A. H.

van Marion, Denise M. S.

Kik, Charles

Steen, Herman

Bogers, Ad J. J. C.

Allessie, Maurits A.

Brundel, Bianca J. J. M.

de Groot, Natasja M. S.
Funding

Funding for this research was provided by:

Hartstichting (2013T096, 2013T144, 2011T046)

Bayer

Boehringer Ingelheim

Erasmus Medical Center fellowship

CoolSingel (212)

LSH-Impulse grant (40-43100-98-008)

LSH-Impulse grant (40-43100-98-008)